Honeywell said on October 16, 2025 its Board approved the spin-off of Advanced Materials into Solstice Advanced Materials, an independent, U.S. publicly traded company, which will be effective on October 30, 2025, and that eligible holders as of the close of business on the record date of October 17, 2025 will receive one share of Solstice common stock for every 4 shares of Honeywell common stock they hold, with the distribution to be one share of Solstice for every 1 shares of Honeywell common stock.

1. 01

   Honeywell said on October 16, 2025 its Board approved the spin-off of Advanced Materials into Solstice Advanced Materials, an independent, U.S. publicly traded company, which will be effective on October 30, 2025, and that eligible holders as of the close of business on the record date of October 17, 2025 will receive one share of Solstice common stock for every 4 shares of Honeywell common stock they hold, with the distribution to be one share of Solstice for every 1 shares of Honeywell common stock.

2. 02

   The company said on September 29, 2025 it permanently divested all of its legacy Bendix asbestos liabilities and certain non-Bendix asbestos liabilities, contributed $1.4 billion in cash, derecognized $1.5 billion in asbestos liabilities, and recorded a pre-tax loss of $148 million in Q3 2025.

3. 03

   Honeywell said net sales in its Aerospace Technologies segment for the 3 months ended September 30, 2025 increased $599 million, driven by higher organic sales of $327 million in Commercial Aviation Aftermarket and higher organic sales of $147 million in Defense and Space.

4. 04

   The company said net cash provided by operating activities for the 9 months ended September 30, 2025 increased $1,388 million compared with the same period in the prior year, driven by receipt of the Resideo indemnification and reimbursement agreement termination payment of $1,590 million and an increase in net income of $424 million, partially offset by an increase in accounts receivable of $817 million.

Key figures

Quarter ended September 30, 2025

Revenue

$10.4B

Operating income

$2.4B

Net income

$1.8B

EPS

$2.86

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.